Evidence map›Paper›PMID 27837013›Full record

ArticleRNA (New York, N.Y.)2017

Partial reconstitution of the RNAi response in human cells using Drosophila gene products.

Edward M Kennedy, Anand V R Kornepati, Hal P Bogerd, Bryan R Cullen

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Small RNA-based antimicrobial immunity.Nature reviews. Immunology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Edward M KennedyDepartment of Molecular Genetics and Microbiology and Center for Virology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Anand V R KornepatiDepartment of Molecular Genetics and Microbiology and Center for Virology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Hal P BogerdDepartment of Molecular Genetics and Microbiology and Center for Virology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Bryan R CullenDepartment of Molecular Genetics and Microbiology and Center for Virology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Duke University · US

Funding

Reconstitution of a protective antiviral RNAi response in somatic human cellsR21AI113098 · NIAID · DUKE UNIVERSITY · PI CULLEN, BRYAN R. · 2014 to 2015
$434k
NIAID NIH HHS R21 AI113098
6 · The paper itself

Abstract

While mammalian somatic cells are incapable of mounting an effective RNA interference (RNAi) response to viral infections, plants and invertebrates are able to generate high levels of viral short interfering RNAs (siRNAs) that can control many infections. In Drosophila, the RNAi response is mediated by the Dicer 2 enzyme (dDcr2) acting in concert with two cofactors called Loqs-PD and R2D2. To examine whether a functional RNAi response could be mounted in human somatic cells, we expressed dDcr2, in the presence or absence of Loqs-PD and/or R2D2, in a previously described human cell line, NoDice/ΔPKR, that lacks functional forms of human Dicer (hDcr) and PKR. We observed significant production of ∼21-nt long siRNAs, derived from a cotransfected double stranded RNA (dsRNA) expression vector, that were loaded into the human RNA-induced silencing complex (RISC) and were able to significantly reduce the expression of a cognate indicator gene. Surprisingly, dDcr2 was able to produce siRNAs even in the absence of Loqs-PD, which is thought to be required for dsRNA cleavage by dDcr2. This result may be explained by our finding that dDcr2 is able to bind the human Loqs-PD homolog TRBP when expressed in human cells in the absence of Loqs-PD. We conclude that it is possible to at least partially rescue the ability of mammalian somatic cells to express functional siRNAs using gene products of invertebrate origin.

Indexed as

RNA InterferenceAnimalsCell EngineeringCell LineDEAD-box RNA HelicasesDrosophila melanogasterDrosophila ProteinseIF-2 KinaseGenetic Complementation TestHumansNuclear Receptor CoactivatorsProtein BindingRibonuclease IIIRNA-Binding ProteinsRNA HelicasesRNA-Induced Silencing ComplexDCR-2 protein, DrosophilaDEAD-box RNA HelicasesDICER1 protein, humanDrosophila ProteinsEIF2AK2 protein, humaneIF-2 KinaseLoqs protein, DrosophilaNCOA6 protein, humanNuclear Receptor CoactivatorsR2D2 protein, DrosophilaRibonuclease IIIRNA-Binding ProteinsRNA HelicasesRNA-Induced Silencing ComplexRNA, Small InterferingDicerDrosophilaRNA interferencesmall interfering RNAs

Identifiers

PMID27837013
PMCPMC5238790
OpenAlexW2554926536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.